These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 15107989)

  • 1. Varicella-zoster virus does not significantly induce cell defence mechanism mediated by the 2-5A/RNase L pathway during its replication cycle.
    Desloges N; Rahaus M; Wolff MH
    Med Microbiol Immunol; 2005 Jan; 194(1-2):25-31. PubMed ID: 15107989
    [TBL] [Abstract][Full Text] [Related]  

  • 2. RNase L inhibitor (RLI) antisense constructions block partially the down regulation of the 2-5A/RNase L pathway in encephalomyocarditis-virus-(EMCV)-infected cells.
    Martinand C; Salehzada T; Silhol M; Lebleu B; Bisbal C
    Eur J Biochem; 1998 Jun; 254(2):248-55. PubMed ID: 9660177
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cloning and characterization of a RNAse L inhibitor. A new component of the interferon-regulated 2-5A pathway.
    Bisbal C; Martinand C; Silhol M; Lebleu B; Salehzada T
    J Biol Chem; 1995 Jun; 270(22):13308-17. PubMed ID: 7539425
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The 2'-5' oligoadenylate/RNase L/RNase L inhibitor pathway regulates both MyoD mRNA stability and muscle cell differentiation.
    Bisbal C; Silhol M; Laubenthal H; Kaluza T; Carnac G; Milligan L; Le Roy F; Salehzada T
    Mol Cell Biol; 2000 Jul; 20(14):4959-69. PubMed ID: 10866653
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Downregulation of RNase L inhibitor correlates with upregulation of interferon-induced proteins (2-5A synthetase and RNase L) in patients with chronic fatigue immune dysfunction syndrome.
    Vojdani A; Choppa PC; Lapp CW
    J Clin Lab Immunol; 1998; 50(1):1-16. PubMed ID: 10189612
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The RNase L inhibitor (RLI) is induced by double-stranded RNA.
    Martinand C; Salehzada T; Silhol M; Lebleu B; Bisbal C
    J Interferon Cytokine Res; 1998 Dec; 18(12):1031-8. PubMed ID: 9877446
    [TBL] [Abstract][Full Text] [Related]  

  • 7. RNase L inhibitor is induced during human immunodeficiency virus type 1 infection and down regulates the 2-5A/RNase L pathway in human T cells.
    Martinand C; Montavon C; Salehzada T; Silhol M; Lebleu B; Bisbal C
    J Virol; 1999 Jan; 73(1):290-6. PubMed ID: 9847332
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A transcriptional signaling pathway in the IFN system mediated by 2'-5'-oligoadenylate activation of RNase L.
    Malathi K; Paranjape JM; Bulanova E; Shim M; Guenther-Johnson JM; Faber PW; Eling TE; Williams BR; Silverman RH
    Proc Natl Acad Sci U S A; 2005 Oct; 102(41):14533-8. PubMed ID: 16203993
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The 2-5A/RNase L pathway and inhibition by RNase L inhibitor (RLI).
    Bisbal C; Salehzada T; Silhol M; Martinand C; Le Roy F; Lebleu B
    Methods Mol Biol; 2001; 160():183-98. PubMed ID: 11265282
    [No Abstract]   [Full Text] [Related]  

  • 10. ABCE1 Regulates RNase L-Induced Autophagy during Viral Infections.
    Ramnani B; Manivannan P; Jaggernauth S; Malathi K
    Viruses; 2021 Feb; 13(2):. PubMed ID: 33670646
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The 2-5A system in viral infection and apoptosis.
    Castelli J; Wood KA; Youle RJ
    Biomed Pharmacother; 1998; 52(9):386-90. PubMed ID: 9856285
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inducible expression of the 2-5A synthetase/RNase L system results in inhibition of vaccinia virus replication.
    Díaz-Guerra M; Rivas C; Esteban M
    Virology; 1997 Jan; 227(1):220-8. PubMed ID: 9007077
    [TBL] [Abstract][Full Text] [Related]  

  • 13. ICP0 prevents RNase L-independent rRNA cleavage in herpes simplex virus type 1-infected cells.
    Sobol PT; Mossman KL
    J Virol; 2006 Jan; 80(1):218-25. PubMed ID: 16352546
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization of RNABP, an RNA binding protein that associates with RNase L.
    Le Roy F; Laskowska A; Silhol M; Salehzada T; Bisbal C
    J Interferon Cytokine Res; 2000 Jul; 20(7):635-44. PubMed ID: 10926206
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The 2-5A/RNase L/RNase L inhibitor (RLI) [correction of (RNI)] pathway regulates mitochondrial mRNAs stability in interferon alpha-treated H9 cells.
    Le Roy F; Bisbal C; Silhol M; Martinand C; Lebleu B; Salehzada T
    J Biol Chem; 2001 Dec; 276(51):48473-82. PubMed ID: 11585831
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Caspase-dependent apoptosis by 2',5'-oligoadenylate activation of RNase L is enhanced by IFN-beta.
    Rusch L; Zhou A; Silverman RH
    J Interferon Cytokine Res; 2000 Dec; 20(12):1091-100. PubMed ID: 11152576
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Activation of RNase L by Murine Coronavirus in Myeloid Cells Is Dependent on Basal Oas Gene Expression and Independent of Virus-Induced Interferon.
    Birdwell LD; Zalinger ZB; Li Y; Wright PW; Elliott R; Rose KM; Silverman RH; Weiss SR
    J Virol; 2016 Jan; 90(6):3160-72. PubMed ID: 26739051
    [TBL] [Abstract][Full Text] [Related]  

  • 18. RNase L plays a role in the antiviral response to West Nile virus.
    Scherbik SV; Paranjape JM; Stockman BM; Silverman RH; Brinton MA
    J Virol; 2006 Mar; 80(6):2987-99. PubMed ID: 16501108
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of hepatitis B virus replication by ligand-mediated activation of RNase L.
    Park IH; Kwon YC; Ryu WS; Ahn BY
    Antiviral Res; 2014 Apr; 104():118-27. PubMed ID: 24509240
    [TBL] [Abstract][Full Text] [Related]  

  • 20. RNase L mediates the antiviral effect of interferon through a selective reduction in viral RNA during encephalomyocarditis virus infection.
    Li XL; Blackford JA; Hassel BA
    J Virol; 1998 Apr; 72(4):2752-9. PubMed ID: 9525594
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.